Elemental composition of bone minerals in women with breast cancer treated with adjuvant tamoxifen

Breast Cancer Research and Treatment

Volumn 37, Issue 2, 1996, Pages 161-168

  Kalef Ezra, J A ^a   Pavlidis, N ^a   Klouvas, G ^a   Karantanas, A ^a,b   Hatzikonstantinou, I ^a   Glaros, D ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

Absorptiometry; Bone minerals; Breast cancer; Neutron activation analysis; Tamoxifen

Indexed keywords

ANTIESTROGEN; ELEMENT; ESTROGEN; PHOSPHORUS; TAMOXIFEN;

ADULT; AGED; ARTICLE; BONE MINERAL; BREAST CANCER; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; FOREARM; HAND; HUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; RISK; SKELETON;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BONE DENSITY; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; PHOSPHORUS; TAMOXIFEN; TIME FACTORS;

EID: 0030032787     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806497     Document Type: Article

References (41)

1. Glimcher M: The nature of the mineral component of bone and the mechanism of calcification. In: Avioli LV, Krane SM (eds) Metabolic bone disease, 2nd edition. WB Saunders, Philadelphia, 1990, pp 42-68
2. Consensus Development Conference: Prophylaxis and treatment of osteoporosis. Osteoporosis Int 1: 114-117, 1991
3. Avioli LV, Lindsay R: The female ostcoporotic syndrome. In: Avioli LV, Krane SM (eds) Metabolic bone disease, 2nd edition. WB Saunders, Philadelphia, 1990, pp 397-451
4. Cole MP, Jone CT, Todd ID: A new anti-oestrogenic agent in breast cancer. An early clinical appraisal of ICI 46474. Br J Cancer 25: 270-275, 1971
5. Prentice RL: Tamoxifen as a potential preventive agent in healthy post-menopausal women, (editorial). J Natl Cancer Inst 82: 1310-1311, 1990
6. Nayfield SG, Karp JE, Ford LG, Dorr FF, Kramer BS: Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 83: 1450-1459, 1991
7. Goulding A, Gold E, Feng W: Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with LHRH agonist buserelin. Bone Miner 18: 143-152, 1992
8. Jordan VC: Overview from the International Conference on long-term tamoxifen therapy for breast cancer (commentary). J Natl Cancer Inst 84: 231-234, 1992
9. Glaros D, Xatzikonstantinou J, Leodiou J, Kalef-Ezra J: A partial body activation analysis technique for the measurement of phosphorus in bone. In: Ellis K, Yasumura S, Morgan W (eds) In Vivo Body Composition Studies. The Institute of Physical Sciences in Medicine, London, 1987, pp 295-299
10. Hatzikonstantinou I, Kalef-Ezra J, Glaros D: In vivo measurement of phosphorus in bones of the human hand by neutron activation analysis: Technical aspects and clinical applications. In: Bracale M, Denoth F (eds) Proceedings of the VI Mediterranean Conference on Medical Physics and Biological Engineering. Pisa, Italy, 1992, pp 755-158
11. International Commission on Radiological Protection: 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Pergamon Press, Oxford, 1991
12. Kalef-Ezra J: Radiation burden to patients from non-invasive techniques for in viva bone composition studies. In: Bracale M, Denoth F (eds) Proceedings of the VI Mediterranean Conference on Medical Physics and Biological Engineering, Pisa, Italy, 1992, pp 759-762
13. Cameron J, Sorenson J. Measurement of bone mineral in vivo: An improved method. Science 142: 230-232, 1963
14. Barnett E, Nordin BE: The radiological diagnosis of osteoporosis. Clin Radiol 11: 166-174, 1960
15. O'Keeffe D: Morphometry. Radiol Clin North Am 29: 165-177, 1991
16. Fornander T, Rutqvist LE, Wilking N, Carlström K, von Schoultz B: Oestrogenic effects of adjuvant tamoxifen in post-menopausal breast cancer. Eur J Cancer 29: 497-500, 1993
17. Basle MF, Mauras Y, Audran M, Clochon P, Rabel A, Allain P: Concentration of bone elements in osteoporosis. J Bone Miner Res 5: 41-47, 1990
18. Kalef-Ezra J, Glaros D, Klouvas G, Hatzikonstantinou J, Karantanas A, Siamopoulos KC, Pavlidis N: New evidence that tamoxifen does not induce osteoporosis: A nuclear activation analysis and ahsorptiometry. Br J Radiol 65: 417-420, 1992
19. Jordan VC, Phelps E, Lindgren JU: Effects of antiestrogens on bone in castrated and intact female rats. Breast Cancer Res Treat 10: 31-35 (1987)
20. Feldmann S, Minne HW, Pafvizi S, Pfeifer M, Lempert UG, Bauss F, Ziegler R: Antiestrogen and antiandrogen administration reduce bone mass in the rat. Bone Miner 7: 245-254, 1987
21. Kalu DN, Salerno E, Liu CC, Echon R, Ray M, Garza-Zapata M, Hollis BW: A comparative study of the actions of tamoxifen, estrogen and progesterone in the ovariectomized rat. Bone Miner 15: 109-124, 1991
22. Williams DC, Paul DC, Black LJ: Effects of estrogen and tamoxifen on serum osteocalcin in ovariectomized rats. Bone Miner 14: 205-220, 1991
23. Goulding A, Gold E, Feng W: Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRG agonist buserelin. Bone Miner 18: 143-152, 1992
24. Moon LY, Wakley GN, Turner RT: Dose-dependent effects of tamoxifen on long bones in growing rats: influence of ovarian status. Endocrinology 129: 1568-1574, 1991
25. Love RR, Mazess RB, Tormey D, Barden HS, Newcomb PA, Jordan VC: Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years. Breast Cancer Res Treatment 12: 247-302, 1988
26. Wright CDP, Evans WD, Mansel RE, Compston JE: Effects of long term tamoxifen therapy on bone mass (abstract). Bone 11: 221, 1990
27. Fornander T, Rutqvist LE, Sjöberg HE, Blomqvist L, Mattson A, Glas U: Long-term adjuvant tamoxiten in early breast cancer: Effect on bone mineral density in postmenopausal women. J Clin Oncol 8:1019-1024, 1990
28. Li I, Pitt PI, Sherwood R, Parsons V, Moniz C: Biochemical markers of bone turnover in women who had received tamoxifen for breast cancer (abstract). Bone Miner 17 (Suppl 1): 213, 1992
29. Neal AJ, Evans K, Hoskin PJ: Measurement of the effect of tamoxifen on bone mineral density (abstract). Br J Radiol 66 (Suppl): 49-50, 1993
30. Utz JP, Melton LJ, Kan BL: Risk of osteoporotic fractures in women with breast cancer: a population-based cohort study, J Chron Dis 40: 105-113, 1987
31. Gotfredsen A, Christiansen C, Palshof T: The effect of tamoxifen on bone mineral content in prcmenopausal women with breast cancer. Cancer 53: 853-857, 1984
32. Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, Carbone PP, DeMets DL: Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. New Engl J Med 326: 852-856, 1992
33. Fentiman IS, Calefi M, Rodin A et al: Bone mineral content of women receiving tamoxifen for mastalgia. Br J Cancer 60: 261-263, 1989
34. Fentiman IS, Saad Z, Caleffi M, Chaudary MA, Fogelman I: Tamoxifen protects against steroid induced bone loss. Eur J Cancer 28: 684-685, 1992
35. Turken S, Siris E, Seldin D, Flaster E, Hyman G, Lindsay R: Effects of tamoxifen on spinal bone density in women with breast cancer. J Natl Cancer Inst 81: 1086-1088, 1989
36. Ryan WG, Wolter J, Bagdade JD: Apparent beneficial effects on bone mineral content in patients with breast cancer: Preliminary results. Osteoporosis Int 2: 39-41, 1991
37. Ward RL, Morgan G, Dalley D, Kelly PJ: Tamoxifen reduces bone turnover and prevents lumbar spine and proximal bone loss in early postmenopausal women. Bone Miner 22: 87-94, 1993
38. Kristensen B, Ejlertsen B, Dalgaard P, Larsen L, Holmegaard SN, Transböl I, Mouridsen HT: Tamoxifen and bone mineral metabolism in postmenopausal low risk breast cancer patients: A randomized study. J Clin Oncol 12: 992-997, 1994
39. Wright CDP, Garrahan NJ, Stanton M, Gazet JC, Mansell RE, Compson JE: Effect of long-term tamoxifcn therapy on calccllous bone remodeling and structure in women with breast cancer. J Bone Miner Res 9: 153-159, 1994
40. Fentiman IS, Fogelman I: Breast cancer and osteoporosis - A bridge at last. Eur J Cancer 29A: 485-486, 1993
41. Charkes DN, Silverman C: Does radiotherapy affect regional bone formation? (editorial). J Nuclear Med 33: 1780-1782, 1992